BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://oncodaily.com X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Halifax BEGIN:DAYLIGHT TZOFFSETFROM:-0400 TZOFFSETTO:-0300 TZNAME:ADT DTSTART:20250309T060000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0300 TZOFFSETTO:-0400 TZNAME:AST DTSTART:20251102T050000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0400 TZOFFSETTO:-0300 TZNAME:ADT DTSTART:20260308T060000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0300 TZOFFSETTO:-0400 TZNAME:AST DTSTART:20261101T050000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0400 TZOFFSETTO:-0300 TZNAME:ADT DTSTART:20270314T060000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0300 TZOFFSETTO:-0400 TZNAME:AST DTSTART:20271107T050000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Kolkata BEGIN:STANDARD TZOFFSETFROM:+0530 TZOFFSETTO:+0530 TZNAME:IST DTSTART:20250101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20260220T090000 DTEND;TZID=America/New_York:20260220T100000 DTSTAMP:20260404T111708 CREATED:20260124T234805Z LAST-MODIFIED:20260124T234834Z UID:10000619-1771578000-1771581600@oncodaily.com SUMMARY:CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia - Resonance DESCRIPTION:The ALRCaN Global webinar\, titled “CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia\,” is scheduled for Friday\, February 20\, 2026\, at 09:00 AM ET. Featuring Dr. Hannah Lust\, the session will focus on the evolving treatment landscape for Adolescent and Young Adult (AYA) patients\, specifically examining the transition and relationship between CAR T-cell therapy and hematopoietic stem cell transplantation. \nHosted by Resonance Health and created by Ivana Cáceres\, the event is supported by the leadership of Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. This discussion provides a global forum for oncology professionals to explore integrated therapeutic strategies aimed at optimizing long-term outcomes for the AYA leukemia population. URL:https://oncodaily.com/event/car-t-cell-therapy-446541 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Hannah-Lust.webp LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260220 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251224T105230Z LAST-MODIFIED:20251224T105245Z UID:10000524-1771545600-1771718399@oncodaily.com SUMMARY:5th CECOG Breast Cancer Academy DESCRIPTION:The 5th CECOG Breast Cancer Academy\, organized by the Central European Cooperative Oncology Group (CECOG)\, is a specialized educational event taking place on February 20-21\, 2026\, in Vienna\, Austria. \nHeld at the ARCOTEL AQ\, the academy is designed for oncology professionals to explore current standards and emerging challenges in both early and advanced breast cancer management. Led by a scientific committee of Austrian experts\, the program features expert-led sessions on clinical scenarios and offers CME accreditation to enhance the professional development of its participants. URL:https://oncodaily.com/event/cecog-breast-cancer-433294 LOCATION:ARCOTEL AQ\, Althanstraße 8\, Vienna\, Vienna\, 1090\, Austria ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/CECOG.webp ORGANIZER;CN="Central European Cooperative Oncology Group (CECOG)":MAILTO:office@cecog.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260220 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251215T185942Z LAST-MODIFIED:20251215T185950Z UID:10000497-1771545600-1771718399@oncodaily.com SUMMARY:Oncology APP Leadership Forum 2026 DESCRIPTION:The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders\, managers\, administrators\, and directors in oncology. \nScheduled for February 20–21\, 2026\, at the Circa Resort and Casino in Las Vegas\, the forum focuses on equipping APP leaders with the knowledge and skills to become more effective leaders in their organizations. Key topics on the agenda include critical conversations in the workplace\, utilizing AI in leadership\, constructing an APP billing dashboard\, building leadership education frameworks\, and a workshop on burnout and boundary setting. \nRegister. URL:https://oncodaily.com/event/oncology-app-leadership-forum-429017 LOCATION:Circa Resort & Casino\, 8 Fremont St\, Las Vegas\, NV\, 89101\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Oncology-APP-Leadership-Forum-2026.webp ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260220 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251209T213259Z LAST-MODIFIED:20251209T213315Z UID:10000467-1771545600-1771718399@oncodaily.com SUMMARY:Highlights in GI Oncology DESCRIPTION:The Highlights in GI Oncology conference\, hosted by Horizon CME\, is a two-day educational program providing the latest science and practice-changing advances from the world’s premier GI oncology event\, the ASCO Gastrointestinal Cancers Symposium. \nThe CME initiative\, designed for a multidisciplinary audience including oncologists\, surgeons\, and nurses\, is scheduled for February 20–21\, 2026\, at the Orlando World Center Marriott. Expert faculty will review the most recent research and treatment strategies for various GI cancers\, including colorectal\, pancreatic\, biliary\, and neuroendocrine cancers\, applying the findings to patient case contexts. \nRegister. URL:https://oncodaily.com/event/highlights-in-gi-oncology-425076 LOCATION:Orlando World Center Marriott\, 8701 World Center Dr\, Orlando\, FL\, 32821\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Screenshot-2025-12-10-013028.webp ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260220 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251201T203902Z LAST-MODIFIED:20251201T203902Z UID:10000435-1771545600-1771718399@oncodaily.com SUMMARY:APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit DESCRIPTION:The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME\, scheduled for February 20th – 21st\, 2026\, at the Circa Resort and Casino in Las Vegas\, Nevada. \nThe summit is specifically tailored for Advanced Practice Providers (APPs)\, including Nurse Practitioners (NPs)\, Physician Assistants (PAs)\, pharmacists\, and nurses\, with the primary goal of providing the latest evidence-based strategies to optimize care and outcomes for patients with cancer. \nRegister. URL:https://oncodaily.com/event/419963 LOCATION:Circa Resort & Casino\, 8 Fremont St\, Las Vegas\, NV\, 89101\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/APPOS-Las-Vegas.webp ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260219T190000 DTEND;TZID=America/New_York:20260219T200000 DTSTAMP:20260404T111708 CREATED:20260126T012807Z LAST-MODIFIED:20260126T012831Z UID:10000626-1771527600-1771531200@oncodaily.com SUMMARY:Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care DESCRIPTION:The Multinational Association of Supportive Care in Cancer (MASCC)\, in partnership with SIOG-NAHS and JASCC Geriatrics\, will host a webinar titled “Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care“. \nScheduled for Thursday\, February 19\, 2026\, the session runs from 7:00 PM to 8:00 PM EST. The agenda includes discussions on geriatric assessment in Japan and evidence-based integrative medicine\, featuring a panel led by co-chairs Dr. Ayumu Matsuoka and Dr. Sriram Yennu\, alongside Dr. Lisa Guccione and Dr. Kelly McConnell. URL:https://oncodaily.com/event/geriatric-oncology-447041 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/MASCC-1.webp LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Halifax:20260219T120000 DTEND;TZID=America/Halifax:20260219T130000 DTSTAMP:20260404T111708 CREATED:20251210T223125Z LAST-MODIFIED:20251210T223148Z UID:10000471-1771502400-1771506000@oncodaily.com SUMMARY:Advocates Webinar: Modernizing Oncology Endpoints DESCRIPTION:The Advocates Webinar: Modernizing Oncology Endpoints\, hosted virtually by Friends of Cancer Research (Friends)\, is a free\, advocates-focused session scheduled for Thursday\, February 19\, 2026\, from 12:00 PM to 1:00 PM ET. \nThe webinar will build upon the public meeting held earlier in the month\, focusing on translating complex scientific and policy discussions into accessible\, advocacy-focused insights concerning two emerging tools in cancer drug development: circulating tumor DNA (ctDNA) and Artificial Intelligence (AI)-based tumor assessment tools. The goal is to explain how these biomarkers and technologies can accelerate evidence generation and clinical trial efficiency to support earlier patient access to treatments. \nRegister. URL:https://oncodaily.com/event/advocates-webinar-425835 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/webinar.webp LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260219 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251026T210410Z LAST-MODIFIED:20251026T210435Z UID:10000291-1771459200-1771718399@oncodaily.com SUMMARY:2026 Multidisciplinary Head and Neck Cancers Symposium by ASTRO DESCRIPTION:The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21\, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies\, the symposium will be held both in-person in Palm Desert\, California\, and as a live virtual meeting online. \nThe central theme for the 2026 meeting is “Advancing Patient-Centered Care Through Innovative Team Science.” The conference aims to foster meaningful collaboration among radiation oncologists\, medical oncologists\, surgeons\, and other specialists to share the most current\, evidence-based practices in the field. \nThe program is structured to deliver practical insights through educational sessions\, interactive case discussions\, and oral abstract presentations. It serves as a forum for presenting and discussing new data\, with the Call for Abstracts remaining open until October 8\, 2025. The core objective of the symposium is to improve patient outcomes by advancing multidisciplinary treatment approaches and team-based care for head and neck cancers. Registration and housing are currently open for attendees. URL:https://oncodaily.com/event/head-and-neck-cancers-398768 LOCATION:JW Marriott Desert Springs Resort and Spa\, 74-855 Country Club Dr.\, Palm Desert\, CA\, 92260\, United States ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/image-25.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Halifax:20260218T081500 DTEND;TZID=America/Halifax:20260220T190000 DTSTAMP:20260404T111708 CREATED:20251213T013628Z LAST-MODIFIED:20251213T013743Z UID:10000484-1771402500-1771614000@oncodaily.com SUMMARY:2026 International Cancer Neuroscience Symposium DESCRIPTION:The 2026 International Cancer Neuroscience Symposium\, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley’s Advanced Portfolio\, is a three-day dynamic hybrid event scheduled for Wednesday\, February 18\, to Friday\, February 20\, 2026. \nThe in-person component will be held at the TMC3 Collaborative Building in Houston\, Texas. This biennial symposium aims to integrate the fields of oncology\, neuroscience\, cancer biology\, neuroimmunology\, and mental health\, bringing together over 30 leading international experts to share key insights and cutting-edge research to foster innovation in cancer research and enhance patient care. \nRegister. URL:https://oncodaily.com/event/international-cancer-neuroscience-symposium-426891 LOCATION:TMC3 Collaborative Building\, 7255 Helix Park Ave\, Houston\, TX\, 77030\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/1754434517156.webp END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Halifax:20260218T080000 DTEND;TZID=America/Halifax:20260221T170000 DTSTAMP:20260404T111708 CREATED:20250717T130123Z LAST-MODIFIED:20250717T130143Z UID:10000220-1771401600-1771693200@oncodaily.com SUMMARY:AACR IO Conference 2026 DESCRIPTION:The AACR IO Conference 2026\, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy\, will take place from February 18–21\, 2026\, at JW Marriott Los Angeles L.A. Live. \nLed by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas\, the event will focus on cutting-edge research in cancer immunology\, highlighting breakthroughs in immuno-oncology (IO) drugs\, inflammatory modulators\, vaccines\, and cellular therapies. \nBuilding on the success of AACR IO 2025\, which drew over 600 participants\, AACR IO 2026 promises a comprehensive program including keynote lectures\, symposia\, spotlight sessions\, educational content\, and poster presentations. This forum offers a valuable opportunity for scientists\, clinicians\, industry leaders\, and advocates to engage with the latest advances in cancer immunotherapy. \nMore posts featuring AACR. URL:https://oncodaily.com/event/aacr-io-conference-2026-331172 LOCATION:JW Marriott Los Angeles L.A. Live\, 900 W Olympic Blvd\, Los Angeles\, CA\, Los Angeles\, 90015\, United States ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/07/download-7.png ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260218 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251222T215456Z LAST-MODIFIED:20251222T215529Z UID:10000521-1771372800-1771718399@oncodaily.com SUMMARY:Targeted Therapies of Lung Cancer (TTLC 2026) DESCRIPTION:The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) meeting is a premier international conference scheduled for February 18–21\, 2026\, in Huntington Beach\, California. \nOrganized by the International Association for the Study of Lung Cancer (IASLC)\, this landmark event brings together global experts\, clinicians\, and researchers to share the latest breakthroughs in preclinical research and data from cutting-edge clinical trials. The symposium serves as a critical forum for discussing how emerging molecular targets and novel treatments are actively transforming clinical practice and treatment guidelines for thoracic malignancies. \nRegister. URL:https://oncodaily.com/event/targeted-therapies-of-lung-cancer-432816 LOCATION:Hyatt Regency Huntington Beach Resort And Spa\, 21500 Pacific Coast Hwy\, Huntington Beach\, CA\, 92648\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/TTLC-1.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260218 DTEND;VALUE=DATE:20260222 DTSTAMP:20260404T111708 CREATED:20251102T220138Z LAST-MODIFIED:20251102T220151Z UID:10000308-1771372800-1771718399@oncodaily.com SUMMARY:Targeted Therapies of Lung Cancer 2026 DESCRIPTION:The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting\, organized by the International Association for the Study of Lung Cancer (IASLC)\, is a premier event for experts dedicated to advancing lung cancer care. The meeting is scheduled to begin on February 18\, 2026\, and will be held in Huntington Beach\, California. The conference is a must-attend event that brings together leading researchers\, clinicians\, and industry experts to share the latest breakthroughs in clinical research\, focusing on innovation in targeted therapies for thoracic malignancies. \nYou can find more posts featuring IASLC on OncoDaily. URL:https://oncodaily.com/event/targeted-therapies-402227 LOCATION:Hyatt Regency Huntington Beach Resort And Spa\, 21500 Pacific Coast Hwy\, Huntington Beach\, CA\, 92648\, United States ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/IASLC.jpg ORGANIZER;CN="International Association for the Study of Lung Cancer (IASCL)":MAILTO:info@iaslc.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260218 DTEND;VALUE=DATE:20260221 DTSTAMP:20260404T111708 CREATED:20260126T011556Z LAST-MODIFIED:20260126T011603Z UID:10000624-1771372800-1771631999@oncodaily.com SUMMARY:Advancing Cancer Research for Latinos and All Populations DESCRIPTION:The Advancing Cancer Research for Latinos and All Populations conference is a biennial international event scheduled for February 18-20\, 2026\, in San Antonio\, Texas. \nHosted by the Mays Cancer Center and the Institute for Health Promotion Research at UT Health San Antonio\, this conference addresses the critical health disparities facing Latinos\, for whom cancer remains a leading cause of death\, and who often face significant barriers to screening\, treatment\, and palliative care. The summit unites a diverse group of stakeholders – including survivors\, caregivers\, researchers\, and physicians – to translate basic research into clinical best practices and effective community interventions. \nRegister. URL:https://oncodaily.com/event/advancing-cancer-research-447028 LOCATION:Plaza San Antonio Hotel & Spa\, Autograph Collection\, 555 S Alamo St\, San Antonio\, TX\, 78205\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Latinos.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260218 DTEND;VALUE=DATE:20260220 DTSTAMP:20260404T111708 CREATED:20251126T002120Z LAST-MODIFIED:20251126T002132Z UID:10000403-1771372800-1771545599@oncodaily.com SUMMARY:ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano DESCRIPTION:The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer\, providing oncologists with a thorough understanding of current standards of care\, molecular pathology\, and novel treatment targets. \nThe preceptorship will take place on February 18–19\, 2026\, in Lugano\, Switzerland\, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11\, 2025. \nApply. URL:https://oncodaily.com/event/esmo-preceptorship-416470 LOCATION:Lugano\, Switzerland ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-1-1.webp ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260218 DTEND;VALUE=DATE:20260219 DTSTAMP:20260404T111708 CREATED:20251227T145119Z LAST-MODIFIED:20251227T145133Z UID:10000537-1771372800-1771459199@oncodaily.com SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 DESCRIPTION:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18\, 2026\, focused on the safety profiles and clinical management of next-generation biologics. \nChaired by Elena Garralda\, the program features expert discussions on the molecular mechanisms of on-target/off-tumor effects and evaluates emerging mitigation strategies to optimize patient outcomes. This virtual event\, part of the ESMO Therapeutic Landscapes series\, provides attendees with 1 ESMO-MORA category 1 point and serves as a vital forum for clinicians to refine their expertise in navigating the complexities of modern immunotherapy toxicity. \nRegister. URL:https://oncodaily.com/event/esmo-therapeutic-landscapes-434705 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Therapeutic-Landscapes.webp ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260217 DTEND;VALUE=DATE:20260319 DTSTAMP:20260404T111708 CREATED:20260122T145425Z LAST-MODIFIED:20260122T145425Z UID:10000613-1771286400-1773878399@oncodaily.com SUMMARY:ASTRO's Multidisciplinary Radiopharmaceutical Therapy Symposium DESCRIPTION:The Multidisciplinary Radiopharmaceutical Therapy Symposium (MRPTS) will be held February 17–18\, 2026\, at JW Marriott Desert Springs\, Palm Desert\, California\, with a live virtual option for remote attendees. \nThis inaugural symposium brings together experts across disciplines to explore the evolving use and latest advancements in radiopharmaceuticals for cancer and other indications. Under the theme “From Start-Up to State-of-the-Art: A Collaborative Journey\,” participants will gain insights into translational research\, clinical applications\, and collaborative innovations driving the next generation of radiopharmaceutical therapies. \nRegister Now. URL:https://oncodaily.com/event/radiopharmaceutical-therapy-445044 LOCATION:JW Marriott Desert Springs Resort & Spa\, 74-855 Country Club Drive\, Palm Desert\, CA\, 92260\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Annotation-2026-01-22-185402.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260216 DTEND;VALUE=DATE:20260219 DTSTAMP:20260404T111708 CREATED:20251204T143844Z LAST-MODIFIED:20251204T143910Z UID:10000446-1771200000-1771459199@oncodaily.com SUMMARY:SCION Workshop 2026 DESCRIPTION:The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate\, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC)\, designed to address the unique challenges in designing protocols specific to cancer immunotherapy. \nThe 2026 SCION Workshop is scheduled for February 16-18\, 2026\, and will be held at The Westin Copley Place\, Boston. Participation requires an application with a proposed protocol abstract and includes a mandatory 90-day post-workshop report to ensure progress in clinical trial development. URL:https://oncodaily.com/event/scion-421390 LOCATION:The Westin Copley Place\, Boston\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/16_9-1.jpg ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Kolkata:20260215T160000 DTEND;TZID=Asia/Kolkata:20260215T170000 DTSTAMP:20260404T111708 CREATED:20260214T122914Z LAST-MODIFIED:20260214T130840Z UID:10000653-1771171200-1771174800@oncodaily.com SUMMARY:ICCD 2026 National Webinar: From Policy to Practice in Childhood Cancer Care DESCRIPTION:On the occasion of International Childhood Cancer Day (ICCD) 2026\, observed globally on 15 February to raise awareness and promote equitable access to quality cancer care for every child\, a National Webinar will convene leading experts and advocates from across India. \nCentered on the theme\, “From Policy to Practice: What Do We Really Need to Improve Childhood Cancer Care in India?” the virtual session (15 February 2026 | 4:00–5:00 PM IST) will focus on translating policy frameworks into real-world improvements in diagnosis\, treatment access\, survivorship\, and patient support systems. \nKey Highlights: \nKeynote Address: Dr. Ravi Kannan – Padma Shri Awardee\, Cancer Care Visionary and Public Health Leader \nSession Chair: Dr. Satya Yadav – Chairperson\, PHO–IAP \nSession Moderator: Dr. Shweta Bansal – Secretary\, PHO–IAP \nPanelists: \n\nDr. Gevorg Tamamyan – Editor-in-Chief\, OncoDaily; President\, POEM Group and SIOP Asia\nDr. Rejin Kubudi – General Secretary\, SIOP Society\nDr. Rajesh Kasle – Senior Pediatrician; President\, IAP Mumbai\nDr. Girish Chinnaswamy – Head\, PHO\, TMH Mumbai\nAlka Bisen – CEO\, CPAA (Cancer Patients Aid Association)\n\nBringing together clinicians\, public health leaders\, and patient advocates\, the webinar aims to foster actionable dialogue and collaborative strategies to strengthen childhood cancer care delivery across India. URL:https://oncodaily.com/event/childhood-cancer-455577 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-14T164300.761-1280x720-1-1.webp ORGANIZER;CN="Pediatric Hematology &%3B Oncology (PHO) Chapter of the Indian Academy of Pediatrics (IAP)":MAILTO:secy.pho@gmail.com LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Halifax:20260214T090000 DTEND;TZID=America/Halifax:20260214T170000 DTSTAMP:20260404T111708 CREATED:20260114T211119Z LAST-MODIFIED:20260114T211132Z UID:10000572-1771059600-1771088400@oncodaily.com SUMMARY:2026 Precision Oncology Workshop: From Genomics to Therapeutics DESCRIPTION:The 2026 Precision Oncology Workshop: From Genomics to Therapeutics is a high-impact clinical event focused on the translation of genetic data into innovative cancer treatments. \nOrganized by the Private Cancer Physicians of Australia (PCPA) in collaboration with LifeStrands Genomics\, the workshop is scheduled for February 14\, 2026\, in Brisbane. The program is specifically designed for medical oncologists\, pathologists\, and geneticists\, providing a comprehensive deep dive into the human genome\, pharmacogenomics\, and the selection of appropriate molecular tests. \nRegister. URL:https://oncodaily.com/event/precision-oncology-workshop-441160 LOCATION:InterContinental Brisbane\, 190 Elizabeth St\, Brisbane\, Brisbane\, QLD 4000\, Australia ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/PCPA-1.webp ORGANIZER;CN="Private Cancer Physicians of Australia (PCPA)":MAILTO:pcpa@amaq.com.au END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Halifax:20260214T083000 DTEND;TZID=America/Halifax:20260214T143000 DTSTAMP:20260404T111708 CREATED:20251218T153252Z LAST-MODIFIED:20251218T153412Z UID:10000513-1771057800-1771079400@oncodaily.com SUMMARY:Best of SABCS – West DESCRIPTION:Best of SABCS – West\, taking place February 14\, 2026\, at the Intercontinental San Francisco\, provides clinicians with the latest updates in breast cancer research\, diagnosis\, and treatment. \nThe program highlights recent clinical trial results\, advances in management of breast cancer subtypes\, and evidence-based strategies to optimize patient care\, offering AMA PRA Category 1 Credit through the University of Texas at San Antonio. \nRegister here. URL:https://oncodaily.com/event/sabcs-430563 LOCATION:Intercontinental San Francisco\, 888 Howard Street\, San Francisco\, California\, 94103\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-94.webp END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260213T090000 DTEND;TZID=America/New_York:20260213T100000 DTSTAMP:20260404T111708 CREATED:20260124T234537Z LAST-MODIFIED:20260124T234545Z UID:10000618-1770973200-1770976800@oncodaily.com SUMMARY:Novel Reinduction Strategies for Relapsed B-ALL - Resonance DESCRIPTION:The ALRCaN Global webinar\, titled “Novel reinduction strategies for relapsed B-ALL\,” is scheduled for Friday\, February 13\, 2026\, at 09:00 AM ET. This session features Dr. Laura E. Hogan\, who will lead a lively discussion on innovative approaches to reinduction therapy for patients with relapsed B-cell acute lymphoblastic leukemia. \nOrganized through Resonance Health and created by Ivana Cáceres\, the event is supported by a leadership team including Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. The webinar serves as a global platform for clinicians and researchers to explore emerging therapeutic strategies and share insights on improving outcomes for this challenging patient population across various international time zones. URL:https://oncodaily.com/event/relapsed-b-all-446530 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Laura-E-Hogan.webp LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260213 DTEND;VALUE=DATE:20260216 DTSTAMP:20260404T111708 CREATED:20260122T144429Z LAST-MODIFIED:20260122T144429Z UID:10000612-1770940800-1771199999@oncodaily.com SUMMARY:31st Annual Multidisciplinary Symposium on Breast Disease DESCRIPTION:The 31st Annual Multidisciplinary Symposium on Breast Disease will take place February 13–15\, 2026\, at The Ritz Carlton\, Amelia Island\, FL. \nThis premier event offers a comprehensive\, multidisciplinary overview of breast cancer diagnosis and treatment\, spanning surgical\, medical\, and radiation oncology\, as well as pathology\, radiology\, and patient advocacy. Designed for clinicians\, specialists\, and scientists involved in breast cancer care\, research\, and education\, the symposium will highlight current challenges\, emerging advances\, and innovative strategies across all stages of the disease. Participants will gain actionable insights into the latest diagnostic techniques\, treatment approaches\, and therapeutic developments\, enhancing their ability to deliver state-of-the-art care to patients. \nRegister Now. URL:https://oncodaily.com/event/breast-disease-445024 LOCATION:The Ritz Carlton\, Amelia Island\, 4750 Amelia Island Parkway\, Amelia Island\, FL\, 32034\, United States ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/BeFunky-collage-2026-01-22T184442.845.webp ORGANIZER;CN="University of Florida":MAILTO:cme-mail@ufl.edu END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260213 DTEND;VALUE=DATE:20260216 DTSTAMP:20260404T111708 CREATED:20251130T161302Z LAST-MODIFIED:20251130T161317Z UID:10000430-1770940800-1771199999@oncodaily.com SUMMARY:IAPCON 2026: Continuum of Care: Hospital\, Hospice and Home DESCRIPTION:The 33rd Annual International Conference of the Indian Association of Palliative Care (IAPCON 2026) will be held from 13–15 February 2026 at the National Institute for Micro\, Small\, and Medium Enterprises (NI-MSME) in Hyderabad\, India\, with pre-conference workshops on 12 February. \nOrganized by Sparsh Hospice and Basavatarakam Indo American Cancer Hospital and Research Institute\, the conference will focus on the theme “Continuum of Care: Hospital\, Hospice\, and Home\,” highlighting seamless and holistic palliative care across all settings. Attendees can expect keynote addresses\, scientific sessions\, workshops\, and cultural events\, fostering collaboration and the advancement of palliative care in India. URL:https://oncodaily.com/event/iapcon-2026-419009 LOCATION:National Institute for Micro\, Small\, and Medium Enterprise (NI-MSME)\, Street No. 4\, Rahmat Nagar\, Yousufguda\, Hyderabad\, Telangana\, 500045\, India ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-2025-11-30T201210.967.webp ORGANIZER;CN="Indian Association of Palliative Care":MAILTO:info@palliativecare.in END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260213 DTEND;VALUE=DATE:20260215 DTSTAMP:20260404T111708 CREATED:20251204T150430Z LAST-MODIFIED:20251204T150452Z UID:10000450-1770940800-1771113599@oncodaily.com SUMMARY:2026 Highlights of ASH in the Mediterranean\, Middle East\, and North Africa DESCRIPTION:The Highlights of ASH in the Mediterranean\, Middle East\, and North Africa is a two-day program co-hosted by the American Society of Hematology (ASH) and the Turkish Society of Hematology. The event will take place on February 13–14\, 2026\, in Istanbul\, Türkiye\, at the Hilton Istanbul Bomonti Hotel and Conference Center. \nThe program brings together global hematology leaders to discuss the most influential and novel research presented at the latest ASH Annual Meeting\, covering a wide range of topics in malignant and classical hematology. Attendees can expect to connect with experts\, gain insights into local and regional standards of care\, and earn a Certificate of Participation. \nRegister. URL:https://oncodaily.com/event/ash-in-the-mediterranean-421426 LOCATION:Hilton Istanbul Bomonti Hotel & Conference Center\, Merkez\, Silahşör Cd. No:42\, İstanbul\, Şişli\, 34381\, Turkey ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/MMENA.webp ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260212 DTEND;VALUE=DATE:20260214 DTSTAMP:20260404T111708 CREATED:20260128T214419Z LAST-MODIFIED:20260128T214424Z UID:10000641-1770854400-1771027199@oncodaily.com SUMMARY:1st Best of ESMO Levant DESCRIPTION:The 1st Best of ESMO Levant is scheduled to take place on February 12–13\, 2026\, in Sulaymaniyah\, Iraq. \nOrganized by the Iraqi Society of Clinical Oncology (ISCO) in collaboration with ESMO\, this landmark regional conference is designed to bring the most critical clinical updates and practice-changing research from recent ESMO congresses to the Levant region. \nThe event provides a vital platform for local and international oncology experts to discuss the integration of global standards into regional clinical practice\, focusing on enhancing cancer care delivery through education\, research\, and collaborative innovation. URL:https://oncodaily.com/event/best-of-esmo-levant-448598 LOCATION:Grand Millennium Hotel Sulaimani\, Sulaymaniyah\, Sulaymaniyah Governorate\, Sulaymaniyah\, 46001\, Iraq ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-11.webp ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260212 DTEND;VALUE=DATE:20260214 DTSTAMP:20260404T111708 CREATED:20260118T184434Z LAST-MODIFIED:20260118T184518Z UID:10000592-1770854400-1771027199@oncodaily.com SUMMARY:The 17th Assiut Clinical Oncology Department International Conference DESCRIPTION:The 17th Assiut Clinical Oncology Department International Conference is a prominent medical gathering scheduled for February 12–13\, 2026\, in Luxor\, Egypt. \nOrganized by the Assiut University Clinical Oncology Department in collaboration with Arab Organizers\, the conference serves as a platform for oncologists and researchers to share clinical insights and discuss the latest updates in cancer treatment and management. URL:https://oncodaily.com/event/assiut-clinical-oncology-442942 LOCATION:Jolie Ville Luxor\, Awameya Road\, Gazirat Al Awameyah\, Luxor\, 1360002\, Egypt ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/17-2.webp ORGANIZER;CN="Arab Organizers":MAILTO:info@araborganizers.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260211 DTEND;VALUE=DATE:20260213 DTSTAMP:20260404T111708 CREATED:20251213T011531Z LAST-MODIFIED:20251213T011531Z UID:10000481-1770768000-1770940799@oncodaily.com SUMMARY:ICISi Masterclass in Current Topics of Renal and Adrenal Imaging DESCRIPTION:The ICISi Masterclass in Current Topics of Renal and Adrenal Imaging is a live\, virtual\, workstation-based teaching course delivered over two half-days on February 11–12\, 2026\, starting at 1:00 PM. \nHosted by the International Cancer Imaging Society (ICIS)\, the Masterclass aims to provide a comprehensive overview and diagnostic approach for complex renal and adrenal imaging\, including the evaluation of cystic and solid renal masses using the Bosniak classification\, and assessing incidental and functional adrenal disorders according to current guidelines. \nAttendees will benefit from mentored\, hands-on\, case-based learning with individual workstations and will receive a comprehensive workbook featuring the 35–40 cases reviewed\, with the overall goal of providing radiologists with practical tips and key information necessary for appropriate patient management. \nRegister. URL:https://oncodaily.com/event/icisi-masterclass-426877 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ICIS.webp ORGANIZER;CN="International Cancer Imaging Society (ICIS)":MAILTO:admin@cancerimagingsociety.org.uk LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260211 DTEND;VALUE=DATE:20260212 DTSTAMP:20260404T111708 CREATED:20260117T193624Z LAST-MODIFIED:20260117T193632Z UID:10000589-1770768000-1770854399@oncodaily.com SUMMARY:Minimal Residual Disease in Multiple Myeloma: Foundations and Clinical Relevance DESCRIPTION:The SPCC (Sharing Progress in Cancer Care) webinar\, titled “MRD in multiple myeloma: foundations and clinical relevance\,” is a high-level educational session scheduled for February 11\, 2026. \nAs Minimal Residual Disease (MRD) transitions from a clinical trial endpoint to a critical tool for personalized oncology\, this webinar aims to bridge the gap between scientific theory and daily clinical practice. Led by a panel of world-renowned experts\, the session will explore how ultra-sensitive detection technologies – capable of identifying a single cancer cell among a million healthy ones – are redefining what it means for a patient to be in “remission.” URL:https://oncodaily.com/event/minimal-residual-disease-442403 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-3.webp ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260211 DTEND;VALUE=DATE:20260212 DTSTAMP:20260404T111708 CREATED:20251126T120522Z LAST-MODIFIED:20251126T120536Z UID:10000406-1770768000-1770854399@oncodaily.com SUMMARY:RWD and Digital Oncology: EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026 DESCRIPTION:The Real World Data and Digital Oncology webinar\, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026\, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework. \nThe live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging AI-driven biomarkers can be effectively assessed\, validated\, and integrated into clinical decision-making. \nRegister. URL:https://oncodaily.com/event/digital-oncology-416739 ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.webp ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org LOCATION: END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260210 DTEND;VALUE=DATE:20260212 DTSTAMP:20260404T111708 CREATED:20251117T110612Z LAST-MODIFIED:20251117T110734Z UID:10000366-1770681600-1770854399@oncodaily.com SUMMARY:Signalling Circuits in Cancer DESCRIPTION:The European Association for Cancer Research (EACR) conference\, “Signalling Circuits in Cancer\,” is a Virtual Event scheduled for February 10–11\, 2026. This event will focus on the fundamental mechanisms that control cancer cell signalling circuits and how they govern cancer progression and resistance to therapy. \nThe conference will highlight how therapy resistance is often initiated by non-genetic signalling rewiring via post-translational regulation of proteins. The educational focus is on mechanistic aspects of post-translational and transcriptional regulation\, proteogenomic signal integration\, and RNA biology in cancer\, aiming to open novel insights for the development of new cancer therapies and diagnostics. \nRegister. URL:https://oncodaily.com/event/signalling-circuits-in-cancer-411044 ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/vSIG26_banner_3.jpg ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org END:VEVENT END:VCALENDAR